2012 Biotech Report
BIO Ventures for Global Health (BVGH) and the Biotechnology Industry Organization (BIO) have collaborated on a new report that builds upon the findings in BVGH’s previous analysis, Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape, to delve deeper into understanding the biotechnology sector’s contributions to neglected disease product development across drugs, vaccines, and diagnostics.
In addition to novel data and analysis, the new report, Biotechnology: Bringing Innovation to Neglected Disease R&D, describes the overall biotechnology business model and identifies some of the challenges facing biotech engagement in global health product development.
DOWNLOAD THE REPORT SNAPSHOT HERE
DOWNLOAD THE FULL REPORT HERE